Skye Bioscience (SKYE) Receivables - Net (2012 - 2014)
Skye Bioscience's Receivables - Net was $35,425 in Q1 2014.
Powered by 
Analysis
Skye Bioscience (SKYE) Receivables - Net (2012 - 2014) Analysis & Trends
At the end of FY2013, Receivables - Net at Skye Bioscience came in at $25,338, up 266.9% from FY2012.
- In earlier years, Receivables - Net was $6,906 in FY2012.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Skye Bioscience | 7.07 Mn | 7.07 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2014 | 35,425.00 |
| Oct 31, 2013 | 25,338.00 |
| Jul 31, 2013 | 28,666.00 |
| Apr 30, 2013 | 32,078.00 |
| Oct 31, 2012 | 6,906.00 |
API Access
Skye Bioscience Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=SKYE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "SKYE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=SKYE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();